MedPath

Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal

Not Applicable
Completed
Conditions
Presbyopia
Interventions
Device: BIOFINITY® MF - AIR OPTIX® AQUA MF
Device: BIOFINITY® MF - PUREVISION® MF
Registration Number
NCT01591499
Lead Sponsor
Coopervision, Inc.
Brief Summary

This is a prospective, multi-centre, randomised, single-blind, cross-over study to compare the BIOFINITY® MULTIFOCAL lens and respectively the AIR OPTIX® AQUA MULTIFOCAL lens (lenses allocated on a ratio of 1/0.5) and the PUREVISION® MULTIFOCAL lens (lenses allocated on a ratio of 1/0.5), in presbyopic patients.

Detailed Description

This is a prospective, multi-centre, randomised, single-blind, cross-over study to compare the BIOFINITY® MULTIFOCAL lens and respectively the AIR OPTIX® AQUA MULTIFOCAL lens (lenses allocated on a ratio of 1/0.5) and the PUREVISION® MULTIFOCAL lens (lenses allocated on a ratio of 1/0.5), in presbyopic patients.

Each subject will have 5 visits with the investigator:

* (V1) An inclusion visit during which the first pair of lenses are fitted;

* (V2) An optimization visit after 7 to 9 days of wearing the first lens;

* (V3) An evaluation visit after an additional 10 to 15 days of wearing the first lens (17 to 24 days) and at which time the second pair of lenses are fitted;

* (V4, V5) Visits are conducted as in V 2 and V3 with the second pair of lenses.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
142
Inclusion Criteria
  • Male and female patients, aged 18 years or older
  • Patients with proven presbyopia
  • Patients who do not wear contact lenses or who wore spherical lenses before being included in the study
  • Myopic patients whose spherical equivalent is less than or equal to 9.00 D (or a "lens" power less than or equal to -8,00 D) or hypermetropic patients whose spherical equivalent is less than or equal to +5.50 D (or a "lens" power less than or equal to +6,00 D) or emmetropic patients for distance vision (plan)
  • Patient able to fill in a diary without help
  • Patients who gave their informed consent to take part in the study
Exclusion Criteria
  • Patients with a contra-indication for wearing contact lenses
  • Patients suffering from any ocular pathology that might interfere with the evaluation of the lenses
  • Patients wearing multifocal lenses or spherical lenses for monovision before being included in the study
  • Astigmatic patients whose cylinder is more than 0.75 D

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
BIOFINITY® MF - PUREVISION® MFBIOFINITY® MF - AIR OPTIX® AQUA MFDuring the first period, the participant will be allocated at random either the test lens pair (Biofinity) or a comparator lens pair (Air Optix or Purevision); during the second period, the participant will crossover to the alternate lens pair. (Biofinity crossover to Air Optix or Purevision) (Air Optix or Purevision crossover to Biofinity)
BIOFINITY® MF - AIR OPTIX® AQUA MFBIOFINITY® MF - PUREVISION® MFDuring the first period, the participant will be allocated at random either the test lens pair (Biofinity) or a comparator lens pair (Air Optix or Purevision); during the second period, the participant will crossover to the alternate lens pair. (Biofinity crossover to Air Optix or Purevision) (Air Optix or Purevision crossover to Biofinity)
BIOFINITY® MF - AIR OPTIX® AQUA MFBIOFINITY® MF - AIR OPTIX® AQUA MFDuring the first period, the participant will be allocated at random either the test lens pair (Biofinity) or a comparator lens pair (Air Optix or Purevision); during the second period, the participant will crossover to the alternate lens pair. (Biofinity crossover to Air Optix or Purevision) (Air Optix or Purevision crossover to Biofinity)
BIOFINITY® MF - PUREVISION® MFBIOFINITY® MF - PUREVISION® MFDuring the first period, the participant will be allocated at random either the test lens pair (Biofinity) or a comparator lens pair (Air Optix or Purevision); during the second period, the participant will crossover to the alternate lens pair. (Biofinity crossover to Air Optix or Purevision) (Air Optix or Purevision crossover to Biofinity)
Primary Outcome Measures
NameTimeMethod
Visual Performance - Comparison of Initial Refraction to Multifocal LensesChange over time measured at V1, V3 and V5

The percentage of participants who obtained binocular distance and near visual acuities (VA) at least as good as their initial refraction assessment. Measured by Initial Refraction. Distance binocular VA (at 5 meters) using the Snellen chart decimal scale and near binocular VA (at 40 cm) using the Parinaud chart (smallest to largest letters, Score P1.5, P2, P4, P5).

Change over time measured at V1 (initial refraction) and at V3 (lens pair one evaluation) and V5 (lens pair two evaluation):

V1 = initial refraction at baseline, V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Secondary Outcome Measures
NameTimeMethod
Visual Performance - Near Visual AcuityMeasured at V3 or V5

Description: The participant's near binocular visual acuity (at 40 cm) using the Parinaud chart (smallest to largest letters, Score P1.5, P2, P4, P5) and reported per lens.

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance - Distance Visual AcuityMeasure at V3 or V5

Description: The participant's distance binocular visual acuity (at 5 meters) using the La Galinet method. (Decimal scale, Excellent=between 5 and 20 tenths at 5 metres and between 1 and 20 tenths at 40 cm)

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance - Quality of Near VisionMeasured at V3 or V5

Patients' subjective rating for quality of near vision by patient diary and reported per lens. (40cm away: reading a newspaper, looking at your watch etc. 0-100, 0=totally blurred, 100=perfectly clear).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance - Quality of Intermediate VisionMeasured at V3 or V5

Patients' subjective rating for quality of intermediate vision by patient diary and reported per lens. (distance equivalent to an arm's length. 0-100, 0=totally blurred, 100=perfectly clear).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance: Distance, High Contrast VisionMeasured at V3 or V5

The number of letters read at a distance of 5 meters under 90% high contrast. Measured by objective assessment and reported per lens. Rated on a visual chart (La Galinet- number of letters read).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance - Quality of Distance VisionMeasured at 17-24 days V3 or V5

Patients' subjective rating for quality of distance vision by patient diary and reported per lens. (driving, looking at a landscape, etc. 0-100, 0=totally blurred, 100=perfectly clear).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance - Near, Low Contrast VisionMeasured at V3 or V5

The number of letters read at a near of 40 centimeters under 10% low contrast. Measured by objective assessment and reported per lens. Rated on a visual chart (La Galinet- number of letters read).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance: Near, High Contrast VisionMeasured at 17-24 days V3 or V5

The number of letters read at a near of 40 centimeters under 90% high contrast. Measured by objective assessment and reported per lens. Rated on a visual chart (La Galinet- number of letters read).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance: Distance, Low Contrast VisionMeasured at V3 or V5

The number of letters read at a distance of 5 meters under 10% low contrast. Measured by objective assessment and reported per lens. Rated on a visual chart (La Galinet- number of letters read).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Subjective Rating of Lens Comfort, FittingMeasured at V3 or V5

Patients' subjective rating for lens comfort by patient diary and reported per lens. (After lens fitting, Scale 0-100, 0=very uncomfortable, 100=very comfortable).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Visual Performance - Near Stereoscopic VisionMeasured at V3 or V5

The mean number of occurrences where the "number of the last figure where the patient equipped with analyzers can make out the raised circle (from number 1 to 9)," performed at a distance of 40 centimeters, using Wirt Vectographic Stereopsis Test. Reported per lens.

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Subjective Rating of Lens Comfort - During DayMeasured at V3 or V5

Patients' subjective rating for lens comfort by patient diary and reported per lens. (During the Day, Scale 0-100, 0=very uncomfortable, 100=very comfortable).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Subjective Rating of Lens Comfort - End of DayMeasured at V3 or V5

Patients' subjective rating for lens comfort by patient diary and reported per lens. (At End of Day, Scale 0-100, 0=very uncomfortable, 100=very comfortable).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Subjective Rating of Lens Comfort - General ComfortMeasured at V3 or V5

Patients' subjective rating for lens comfort by patient diary and reported per lens. (General Comfort, Scale 0-100, 0=very uncomfortable, 100=very comfortable).

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Comfort of Use - Average Wearing TimeMeasured at V3 or V5

The average numbers of hours per day of lens wear by patient. Reported per lens. Calculated by number of hours worn.

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two Patients' subjective rating for lens comfort of use by patient diary and reported per lens. (Average Wearing Time in hours per day)

Lens Preference - ParticipantMeasured at V5

The number of participants who preferred a lens pair rated by diary questionnaire with a limited selected response.("Which pair of lenses did you prefer? The first pair, the second pair). Reported per lens.

Measured at completion of V5 (lens pair two evaluation). Both lenses have been worn. Total time since base line is 34-48 days.

Geometric Performance - Lens CentrationMeasured at V3 or V5

Description: The ophthalmologist's rating of lens centration during "Focus" and "Shift When Blinking" by questionnaire as a limited selected response (Optimal, Decentration Acceptable or Decentration Unacceptable). Assessed with the slit lamp and reported per lens.

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Geometric Performance - Lens MobilityMeasured at 17-24 days V3 or V5

The ophthalmologist's rating of lens movement during blinking by questionnaire as a limited selected response (Optimal, Acceptable with a tendency to be tight, Acceptable with a tendency to be Flat, Unacceptable and too tight, or Unacceptable too flat). Assessed with the slit-lamp and reported per lens.

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Clinical Performance - Lens WettabilityMeasured at 17-24 days V3 or V5

The ophthalmologist's rating of lens wettability by questionnaire as a limited selected response (Zero, Low, Acceptable, Good or Excellent). Assessed with the slit lamp and reported per lens.

Measured at V3 (lens pair one evaluation) or V5 (lens pair two evaluation):

V3 = after 17-24 days of lens wear pair one, V5 = after 17-24 days of lens wear pair two

Lens Preference - OphthalmologistMeasured at 17-24 days V3 or V5

Ophthalmologists preference in terms of lenses rated by questionnaire with a limited selected response. ("Choice of Lens? First pair of lenses, Second pair of lenses") (Biofinity, Air Optix, or Purevision)

Measured at completion of V5 (lens pair two evaluation). Both lenses have been worn. Total time since base line is 34-48 days.

© Copyright 2025. All Rights Reserved by MedPath